Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RI0035
Host Cell : CHO-K1 Size : >1x106 frozen cells/vial
| Cat. No. | CSC-RI0035 |
| Description | This cell line is engineered to overexpress human KCNB1. |
| Background | Kv2.1 is expressed in the brain (cell bodies and dendrites of neurons but not axons, as well as Schwann cells), atria, ventricle, skeletal muscle, cochlea, retina, lung and pulmonary arteries. It is involved in maintaining membrane potential and modulating electrical excitability of both neurons and muscle cells. It is thought that Kv2.1 has a role in the muscle tone of the pulmonary system, as the expression Kv2.1 in pulmonary smooth muscle has been found to be reduced in chronic hypoxic pulmonary hypertension. |
| Target Gene | KCNB1 |
| Gene Species | Homo sapiens (Human) |
| Abbr | CHO-HuKCNB1 |
| Alias | KCNB1, DRK1, KV2.1, h-DRK1 |
| Host Cell | CHO-K1 |
| Host Cell Species | Cricetulus griseus (Chinese hamster) |
| Applications |
1. Gene expression studies 2. Signaling pathway research 3. Drug screening and toxicology 4. Channelopathies research |
| Size | >1x106 frozen cells/vial |
| Stability | Validated for at least 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Storage | Liquid nitrogen |
| Shipping | Dry ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Growth Properties | Adherent |
| Morphology | Epithelial-like |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Gene Name | KCNB1 potassium voltage-gated channel, Shab-related subfamily, member 1 [ Homo sapiens ] |
| Gene Symbol | KCNB1 |
| Synonyms | DRK1; KV2.1; h-DRK1 |
| Gene Description | potassium voltage-gated channel, Shab-related subfamily, member 1 |
| GeneID | 3745 |
| Uni ProtID | Q14721 |
| mRNA Refseq | NM_004975.2 |
| Protein Refseq | NP_004966.1 |
| Chromosome Location | 20q13.2 |
| Function | protein binding; voltage-gated potassium channel activity; |
| Pathway | Calcium Regulation in the Cardiac Cell, organism-specific biosystem; Integration of energy metabolism, organism-specific biosystem; Metabolism, organism-specific biosystem; Neuronal System, organism-specific biosystem; Potassium Channels, organism-specific biosystem; Regulation of Insulin Secretion, organism-specific biosystem; Regulation of Insulin Secretion by Glucagon-like Peptide-1, organism-specific biosystem; |
| MIM | 600397 |
A: By optimizing transfection conditions and selecting appropriate promoters to ensure that the expression level of the KCNB1 gene in CHO cells is close to its physiological expression level in humans.
A: This cell line can be used for screening and evaluating drugs targeting the KCNB1 channel, especially those potentially affecting cardiac and nervous system functions.
A: It can be used to study the electrophysiological properties of the KCNB1 channel, including the dynamics of channel opening and closing, and its response to voltage changes.
A: Consideration should be given to transcriptional regulation, mRNA stability, and post-translational modifications of the protein, all of which can affect the expression of the KCNB1 gene.
A: It can be used to establish cellular models of cardiac diseases and certain neurodegenerative diseases, especially those related to dysfunctions of the KCNB1 channel.
A: Regularly change the culture medium, control cell density, and avoid over-passaging to maintain cell vitality and characteristics.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.